Co-expression of cancer stem cell markers CD24 and CD133 in gastric cancer tissues: Clinicopathological and prognostic significance

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 1

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Stem Cells. Jan 26, 2026; 18(1): 114891
Published online Jan 26, 2026. doi: 10.4252/wjsc.v18.i1.114891

Full Size Figure Download Figure

Figure 2 Survival curves of patients with different CD24/CD133 expression patterns.

Citation: Ma CX, Chen J, Wang JL, Pei S, Zhang ZJ, Xie YS, He X. Co-expression of cancer stem cell markers CD24 and CD133 in gastric cancer tissues: Clinicopathological and prognostic significance. World J Stem Cells 2026; 18(1): 114891
URL: https://www.wjgnet.com/1948-0210/full/v18/i1/114891.htm
DOI: https://dx.doi.org/10.4252/wjsc.v18.i1.114891

Ma CX, Chen J, Wang JL, Pei S, Zhang ZJ, Xie YS, He X. Co-expression of cancer stem cell markers CD24 and CD133 in gastric cancer tissues: Clinicopathological and prognostic significance. World J Stem Cells 2026; 18(1): 114891 [PMID: 41608655 DOI: 10.4252/wjsc.v18.i1.114891]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.